A Functional Role for Prolyl Hydroxylases (PHDs) in Cardiomyopathy
A Functional Role for Prolyl Hydroxylases (PHDs) in Cardiomyopathy
批准号:
8293240
负责人:
Javid J Moslehi
金额:
$13.88万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2014-06-30
关键词:
AcuteAddressAffectAttenuatedBiologyBiomedical ResearchBirthCardiacCardiac MyocytesCardiomyopathiesCardiovascular systemChronicClinical ResearchComplexDataDevelopmentDiseaseFamilyFosteringFunctional disorderGenesGoalsHeartHeart failureHospitalsHypoxiaHypoxia Inducible FactorIncidenceInstructionJointsLong-Term EffectsMammalian CellMediatingMedicalMedicineMentorshipMixed Function OxygenasesModelingModificationMusMuscle CellsMyocardial IschemiaOxygenPathogenesisPatientsPolycythemiaPremature MortalityPrincipal InvestigatorProcollagen-Proline DioxygenaseProtein IsoformsProteinsResearchResearch PersonnelResearch TrainingRoleSignal TransductionStressSumTestingTimeTissuesTrainingTraining ProgramsTumor Suppressor GenesUbiquitinationWomanWorkabstractingaging populationcareercareer developmentdesignforgingin vivomedical schoolsmembermulticatalytic endopeptidase complexnovelpreventprofessorprogramsresponsesoundtranscription factor
中文摘要
描述(由申请人提供):此提案描述了一个为期四年的学术心血管(CV)医学职业发展培训计划。首席研究员已经在布里格姆妇女医院完成了心血管医学的临床和研究培训,并将开始一项研究计划,旨在为独立的生物医学研究事业提供额外的科学培训。该计划将为研究主转录因子缺氧诱导因子-a (HIFa)提供完善的原理和专业知识,因为它适用于心肌细胞生物学和心力衰竭。哈佛医学院医学副教授、心肌细胞生物学专家廖荣林博士和哈佛医学院研究员William Kaelin博士共同指导申请人的科学和职业发展。研究者建立了一种新的PHD2小鼠自发性心力衰竭模型,PHD2是一种调节HIFa稳定和活性的脯氨酸羟化酶。本提案的具体目的是:1)确定PHD2失活在体内和离体心肌细胞中的功能后果。2)测试PHD3是否在体内和特异性地在心脏中部分补偿PHD2的损失3)验证HIFa对于心脏特异性PHD2-/-小鼠心肌病的发展是必要和充分的假设。相关性(见说明):心力衰竭是一个巨大的医疗和社会负担,影响着美国超过500万人,其发病率只会随着人口老龄化和心脏病患者生命的延长而增加。这项研究旨在了解心力衰竭的基本机制,最终目标是找到预防和治疗这种毁灭性疾病的新疗法。(摘要结束)
英文摘要
DESCRIPTION (provided by applicant): This proposal describes a 4 year training program for career development in academic cardiovascular (CV) medicine. The principal investigator has completed clinical and research training in CV medicine at Brigham and Women's Hospital and will embark on a research program designed to provide additional scientific training required for an independent biomedical research career. This program will provide sound principles and expertise for studying the master transcription factor Hypoxia-Inducible Factor-a (HIFa) as it applies to myocyte biology and heart failure. A joint mentorship between Dr. William Kaelin, a Howard Hughes Investigator, Professor of Medicine at Harvard Medical School and a pioneer in cellular signaling in hypoxia, and Dr. Ronglin Liao, associate professor of medicine at Harvard Medical School and an expert in cardiomyocyte biology, has been forged to foster the applicant's scientific and career development. The investigator has established a novel model for spontaneous heart failure in mice deficient in PHD2, a prolyl hydroxylase that regulates the stabilization and activity of HIFa. The specific aims of this proposal are: 1) To determine the functional consequence of PHD2 inactivation in the cardiomycoyte in vivo and ex vivo. 2) To test whether PHD3 partially compensates for PHD2 loss in vivo and specifically in the heart 3) To test the hypothesis that HIFa is necessary and sufficient for the development of cardiomyopathy seen in cardiac- specific PHD2-/- mice. RELEVANCE (See instructions): Heart failure represents an enormous medical and societal burden, affecting over 5 million people in the USA, and its incidence is only increasing with an aging population and prolongation of the lives of cardiac patients. This research aims to understand the fundamental mechanisms of heart failure with the ultimate goal of finding new therapies to prevent and treat this devastating illness. (End of Abstract)
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.mcna.2012.07.008
发表时间:
2012-09
期刊:
MEDICAL CLINICS OF NORTH AMERICA
影响因子:
5.9
作者:
[Groarke, John, Tong, Dan, Khambhati, Jay, Cheng, Susan, Moslehi, Javid]
通讯作者:
Moslehi, Javid
DOI:
10.1016/j.jacbts.2016.05.008
发表时间:
2016-08
期刊:
JACC. Basic to translational science
影响因子:
--
作者:
[Sheng CC, Amiri-Kordestani L, Palmby T, Force T, Hong CC, Wu JC, Croce K, Kim G, Moslehi J]
通讯作者:
Moslehi J
Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension
-
批准号:10670742
-
项目类别:
-
资助金额:$64.65万
-
财政年份:2022
-
负责人:Javid J Moslehi
-
依托单位:
Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension
-
批准号:10554695
-
项目类别:
-
资助金额:$64.65万
-
财政年份:2022
-
负责人:Javid J Moslehi
-
依托单位:
Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension
-
批准号:10183300
-
项目类别:
-
资助金额:$68.06万
-
财政年份:2019
-
负责人:Javid J Moslehi
-
依托单位:
A Functional Role for Prolyl Hydroxylases (PHDs) in Cardiomyopathy
-
批准号:8098024
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2009
-
负责人:Javid J Moslehi
-
依托单位:
A Functional Role for Prolyl Hydroxylases (PHDs) in Cardiomyopathy
-
批准号:7923853
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2009
-
负责人:Javid J Moslehi
-
依托单位:
A Functional Role for Prolyl Hydroxylases (PHDs) in Cardiomyopathy
-
批准号:7713621
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2009
-
负责人:Javid J Moslehi
-
依托单位:
海外基金